T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Accenture
ACN
$109B
| $592M | 0.1% |
3,869,675
+794,615
| +26% | +$115M |
|
227
GSK
GSK
$102B
| $588M | 0.1% |
13,256,282
-110,328
| -0.8% | -$5.1M |
|
228
DTE Energy
DTE
$28.6B
| $584M | 0.09% |
6,273,600
+1,531,185
| +32% | +$146M |
|
229
AvalonBay Communities
AVB
$26.1B
| $584M | 0.09% |
3,272,166
-27,938
| -0.8% | -$5.07M |
|
|
SRCL
230
DELISTED
Stericycle Inc
SRCL
| $575M | 0.09% |
8,461,193
+1,075,854
| +15% | +$73M |
|
231
Northern Trust
NTRS
$34.4B
| $575M | 0.09% |
5,754,348
-689,260
| -11% | -$65.7M |
|
232
DexCom
DXCM
$33.6B
| $573M | 0.09% |
39,954,620
+21,972,072
| +122% | +$286M |
|
|
EVHC
233
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $567M | 0.09% |
16,415,840
+1,088,417
| +7% | +$38.1M |
|
234
Regency Centers
REG
$13.9B
| $554M | 0.09% |
8,011,698
-846,357
| -10% | -$55.9M |
|
235
Cable One
CABO
$198M
| $552M | 0.09% |
785,499
+49,666
| +7% | +$35M |
|
236
AT&T
T
$167B
| $543M | 0.09% |
18,507,996
-575,723
| -3% | -$15.7M |
|
237
ASML
ASML
$686B
| $536M | 0.09% |
3,083,223
+503,605
| +20% | +$88.8M |
|
|
SHPG
238
DELISTED
Shire pic
SHPG
| $531M | 0.09% |
3,422,003
-407,383
| -11% | -$60.4M |
|
239
Pediatrix Medical
MD
$2.13B
| $529M | 0.09% |
9,907,689
-846,658
| -8% | -$39.9M |
|
|
CLGX
240
DELISTED
Corelogic, Inc.
CLGX
| $528M | 0.09% |
11,417,907
+77,018
| +0.7% | +$3.56M |
|
241
Coca-Cola
KO
$372B
| $527M | 0.09% |
11,491,239
-240,314
| -2% | -$11M |
|
242
Webster Financial
WBS
$12.8B
| $525M | 0.09% |
9,355,518
-203,365
| -2% | -$11.1M |
|
243
Intel
INTC
$491B
| $521M | 0.08% |
11,283,656
-288,874
| -2% | -$12.6M |
|
|
ANDV
244
DELISTED
Andeavor
ANDV
| $520M | 0.08% |
4,544,359
-880,163
| -16% | -$94.6M |
|
245
Adient
ADNT
$1.48B
| $519M | 0.08% |
6,600,657
-83,027
| -1% | -$6.7M |
|
246
Exelon
EXC
$46.2B
| $519M | 0.08% |
18,474,182
-24,058,143
| -57% | -$691M |
|
247
Marathon Petroleum
MPC
$93.2B
| $518M | 0.08% |
7,855,966
+895,949
| +13% | +$54.8M |
|
248
Allegion
ALLE
$14.3B
| $513M | 0.08% |
6,452,575
+25,327
| +0.4% | +$2.12M |
|
|
BLUE
249
DELISTED
bluebird bio
BLUE
| $509M | 0.08% |
220,618
+9,350
| +4% | +$19M |
|
250
Casey's General Stores
CASY
$30.9B
| $508M | 0.08% |
4,542,489
-2,291
| -0.1% | -$262K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.